Dr. Jeffrey Weber, MD, PhD
Claim this profileNYU Langone Health
Area of expertise
Melanoma
Jeffrey Weber, MD, PhD has run 4 trials for Melanoma. Some of their research focus areas include:
Skin Melanoma
Jeffrey Weber, MD, PhD has run 1 trial for Skin Melanoma. Some of their research focus areas include:
Affiliated Hospitals
NYU Langone Health
Laura And Isaac Perlmutter Cancer Center At NYU Langone
Clinical Trials Jeffrey Weber, MD, PhD is currently running
Nivolumab
for Cancer
This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from where it first started (primary site) to nearby tissue, lymph nodes, or distant parts of the body (advanced), to other places in the body (metastatic) or cannot removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cabozantinib blocks certain proteins, which may help keep tumor cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. Cabozantinib is a type of tyrosine kinase inhibitor and a type of angiogenesis inhibitor. Chemotherapy drugs, such as platinum containing therapies and fluoropyrimidine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving nivolumab alone and in combination with other treatments, including ipilimumab, cabozantinib, platinum containing therapy, or fluoropyrimidine, may be safe, tolerable, and/or effective in treating patients with autoimmune disorders and advanced, metastatic, or unresectable cancer.
Recruiting
1 award
Phase 1
20 criteria
Sarilumab + Immunotherapy
for Melanoma
This trial tests a combination of drugs, including one usually for arthritis and three for cancer. It targets patients with advanced melanoma that can't be surgically removed. The drugs help the immune system attack the cancer by blocking proteins that help the cancer grow.
Recruiting
2 awards
Phase 2
8 criteria
More about Jeffrey Weber, MD, PhD
Clinical Trial Related
4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Jeffrey Weber, MD, PhD has experience with
- Nivolumab
- Pembrolizumab
- Ipilimumab
- Tocilizumab
- Relatlimab
- MRNA-4157
Breakdown of trials Jeffrey Weber, MD, PhD has run
Melanoma
Skin Melanoma
Skin Cancer
Merkel Cell Carcinoma
Crohn's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey Weber, MD, PhD specialize in?
Jeffrey Weber, MD, PhD focuses on Melanoma and Skin Melanoma. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Jeffrey Weber, MD, PhD currently recruiting for clinical trials?
Yes, Jeffrey Weber, MD, PhD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey Weber, MD, PhD has studied deeply?
Yes, Jeffrey Weber, MD, PhD has studied treatments such as Nivolumab, Pembrolizumab, Ipilimumab.
What is the best way to schedule an appointment with Jeffrey Weber, MD, PhD?
Apply for one of the trials that Jeffrey Weber, MD, PhD is conducting.
What is the office address of Jeffrey Weber, MD, PhD?
The office of Jeffrey Weber, MD, PhD is located at: NYU Langone Health, New York, New York 10016 United States. This is the address for their practice at the NYU Langone Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.